Filing Flows › Recursion Pharmaceuticals (RXRX) › How it makes money
How Recursion Pharmaceuticals (RXRX) makes money
Recursion Pharmaceuticals (RXRX) made $18.6M of revenue in the third quarter 2026 (Q3 2026), +258% from a year earlier. Operating revenue brought in $18.1M (97%); Grant revenue brought in $497K (3%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Operating revenue | $18.1M | 97.3% | +147% | +262% |
| Grant revenue | $497K | 2.7% | +35% | +159% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $18.6M | 100.0% |
| Income tax | $25K | 0.1% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $18.6M | +258% |
| Q2 2026 | $7.7M | -60% |
| Q1 2026 | $6.5M | -56% |
| Q4 2025 | $35.5M | +682% |
| Q3 2025 | $5.2M | -80% |
| Q2 2025 | $19.2M | +33% |
| Q1 2025 | $14.7M | +7% |
From Recursion Pharmaceuticals' 10-Q filed Nov 2, 2026 (on EDGAR).
Questions
How does Recursion Pharmaceuticals make money?
Recursion Pharmaceuticals (RXRX) made $18.6M of revenue in the third quarter 2026 (Q3 2026), +258% from a year earlier. Operating revenue brought in $18.1M (97%); Grant revenue brought in $497K (3%).
What is Recursion Pharmaceuticals' biggest business?
Operating revenue: $18.1M in the third quarter 2026, 97% of revenue, +262% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.